Effects of arsenic-, platinum- and gold-containing drugs on the disposition of exogenous selenium in rats

Toxicological Sciences

Volumn 57, Issue 1, 2000, Pages 22-31

  Gregus, Z ^a   Gyurasics, A ^a   Csanaky, I ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Arsenic; Biliary excretion; Cisplatin; Gold; Melarsoprol; Selenium

Indexed keywords

ARSENIC; AUROTHIOMALATE; CARBOPLATIN; CISPLATIN; GOLD; MELARSONYL POTASSIUM; MELARSOPROL; ORGANOARSENIC DERIVATIVE; PLATINUM; SELENITE; SELENIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIARY EXCRETION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG STRUCTURE; ENZYME SYNTHESIS; MALE; NONHUMAN; RAT;

EID: 0033851394     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/57.1.22     Document Type: Article

References (54)

1. Effect of gold on selenium and glutathione peroxidase activities in rat tissues
2. The mechanism of interaction between cisplatin and selenite
3. 2+ with L-(+)-cystathionine and seleno-L-methionine: Potential relevance to the molecular basis of cisplatin toxicity
4. 1H}DEPT NMR
5. Type I iodothyronine deiodinase is a selenocysteine-containing enzyme
6. The production of organo-metalloidal compounds by microorganisms: Part II. Dimethyl selenide
7. Interaction of gold(I) with the active site of selenium-glutathione peroxidase
8. 12 status on selenium methylation and toxicity in rats: In vivo and in vitro studies
9. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group
10. Chemopreventive agents: Selenium
11. Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles
12. Reduction and binding of arsenate and dimethylarsinate by glutathione: A magnetic resonance study
13. Effect of aurothioglucose on glutathione and glutathione-metabolizing and related enzymes in rat liver and kidney
14. Metabolic aspects of selenium action and toxicity
15. Selenium and heavy metals
16. Formation of dimethyl selenide and trimethylselenonium from selenobetaine in the rat
17. Pathways of selenium metabolism including respiratory excretory products
18. Identification of hydrogen selenide and other volatile selenols by derivatization with 1-fluoro-2,4-dinitrobenzene
19. Chemical transformations of selenium in living organisms. Improved forms of selenium for cancer prevention
20. Dietary control of selenium volatilization in the rat
21. Arsenic, selenium, and African trypanosomiasis
22. Biliary and urinary excretion of inorganic arsenic. Monomethylarsonous acid as a major biliary metabolite in rats
23. Role of glutathione in the biliary excretion of arsenical drugs trimelarsan and melarsoprol
24. Interaction between selenium and group Va-metalloids (arsenic, antimony, and bismuth) in the biliary excretion
25. Disposition of metals in rats: A comparative study of fecal, urinary, and biliary excretion and tissue distribution of eighteen metals
26. Enhancement of selenium excretion in bile by sulfobromophthalein: Elucidation of the mechanism
27. Human placenta thioredoxin reductase: Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds
28. Role of glutathione and methylation in the biliary excretion of selenium. The paradoxical effect of sulfobromophthalein
29. Effect of arsenicals on biliary excretion of endogenous glutathione and xenobiotics with glutathione-dependent hepatobiliary transport
30. Glutathione-dependent biliary excretion of arsenic
31. Highlights of the cancer chemoprevention studies in China
32. Interrelationships of selenium with other trace elements
33. Thioredoxin reductase activity is decreased by selenium deficiency
34. Periodate-oxidized adenosine inhibits the formation of dimethylselenide and trimethylselenonium ion in mice treated with selenite
35. Biosynthesis of dimethyl selenide from sodium selenite in rat liver and kidney cell-free systems
36. Glutathione-associated cis-diaminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance
37. Molecular biology of selenium and its role in human health
38. A global view of human selenium nutrition
39. Selenium metabolism: VI. Effect of arsenic on the excretion of selenium in the bile
40. 'Some die wholly in half a breath' - Gun blueing poisoning
41. Gold disposition in the rat: Studies of its plasma half-life and its urinary, biliary and fecal elimination pathways
42. Physiological and nutritional importance of selenium
43. Effect of arsenic on selenium metabolism in rats
44. Myocrisin-mediated oxidative stress
45. Possible involvement of thioredoxin reductase as well as thioredoxin in cellular sensitivity to cis-diamminedichloroplatinum (II)
46. Selenium: Mechanistic aspects of anticarcinogenic action
47. Gold(I) efflux from auranofin-treated red blood cells: Evidence for a glutathione-gold-albumin metabolite
48. The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats
49. Aurothioglucose inhibits murine thioredoxin reductase activity in vivo
50. Selenocysteine
51. Adverse effects of anti-tumor drug, cisplatin, on rat kidney mitochondria: Disturbances in glutathione peroxidase activity
52. Reduction of cisplatin nephrotoxicity by sodium selenite: Lack of interaction at the pharmacokinetic level of both compounds
53. Cisplatin-induced changes of selenium levels and glutathione peroxidase activities in blood of testis tumor patients
54. Distribution of gold in blood following administration of auranofin (SKandFD-39162)